LACEY HILL: Open Payments
NPI 1255852414 · EDMOND, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,912 in 222 payments from 24 companies in 2025. Trend: 2023 $5,015 · 2024 $4,472 · 2025 $4,912
Food & beverage: $4,912
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 36 | $1,005 |
| Insmed, Inc. | 32 | $686 |
| GlaxoSmithKline, LLC. | 28 | $461 |
| Pulmonx Corporation | 14 | $439 |
| GENZYME CORPORATION | 14 | $416 |
| Verona Pharma, Inc. | 20 | $254 |
| United Therapeutics Corporation | 9 | $245 |
| Amgen Inc. | 13 | $205 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $204 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $192 |
Products named: Arikayce, DUPIXENT, BREZTRI, CHARTIS CATHETER, NUCALA, FASENRA, Ohtuvayre, Tyvaso.
Industry payments across OK — which companies pay providers there.
